Cargando…
Pristimerin, a Triterpenoid, Inhibits Tumor Angiogenesis by Targeting VEGFR2 Activation
Pristimerin is a triterpenoid isolated from Celastrus and Maytenus spp. thathas been shown to possess a variety of biological activities, including anti-cancer activity. However, little is known about pristimerin’s effects on tumor angiogenesis. In this study, we examined the function and the mechan...
Autores principales: | Mu, Xianmin, Shi, Wei, Sun, Lixin, Li, Han, Jiang, Zhenzhou, Zhang, Luyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6268918/ https://www.ncbi.nlm.nih.gov/pubmed/22669041 http://dx.doi.org/10.3390/molecules17066854 |
Ejemplares similares
-
Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2
por: Tu, Yingfeng, et al.
Publicado: (2015) -
Antifungal Activity of Maytenin and Pristimerin
por: Gullo, Fernanda P., et al.
Publicado: (2012) -
Evidence for G-quadruplex in the promoter of vegfr-2 and its targeting to inhibit tumor angiogenesis
por: Salvati, Erica, et al.
Publicado: (2014) -
Corrigendum: Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2
por: Tu, Yingfeng, et al.
Publicado: (2016) -
Evidence for G-quadruplex in the promoter of VEGFR-2 and its targeting to inhibit tumor angiogenesis
por: Salvati, E., et al.
Publicado: (2014)